Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 4

Sponsor Class

OTHER 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

Inosine Monophosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Low Back Pain × Clear all
NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed
4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

NCT02367820 2021-06-22

SUMMIT-LTS

Nektar Therapeutics

Phase 3 Completed
638 enrolled 12 charts

Low Back Pain, Chronic Pain

NCT02519387 2016-07-20

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Mundipharma Pharmaceuticals Sdn. Bhd.

Phase 4 Completed
78 enrolled 9 charts

Arthritis, Rheumatoid, Osteoarthritis, Low Back Pain, Arthralgia, Myalgia

NCT00904280 2009-05-19

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Endo Pharmaceuticals

Phase 3 Completed
239 enrolled

Neoplasms, Pain, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡